January 31, 2015 5:53 PM ET


Company Overview of BEXEL Pharmaceuticals, Inc.

Company Overview

BEXEL Pharmaceuticals, Inc. operates as a drug discovery pharmaceutical company. Its products include orally active small molecules for the treatment of chronic diseases, such as diabetes, inflammation, obesity, immunosuppresion, and cancer. The company was founded in 2002 and is based in Union City, California. BEXEL Pharmaceuticals, Inc. is a subsidiary of Orchid Chemicals & Pharmaceuticals Ltd.

32990 Alvarado Niles Road

Suite 910

Union City, CA 94587

United States

Founded in 2002





Key Executives for BEXEL Pharmaceuticals, Inc.

Co-Founder and Director
Co-Founder and Director of Product Development - Animal Physiology & Toxicology
Director of Chemistry & CMC
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Sanford Applied Biosciences, LLC United States
PharmaNova, Inc. United States
Actavis Mid-Atlantic, LLC United States
Plymouth Pharmaceuticals, Inc. United States
PharmaMar USA, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEXEL Pharmaceuticals, Inc., please visit www.bexelpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.